Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: J Cancer Surviv. 2023 Mar 14;17(3):646–656. doi: 10.1007/s11764-023-01354-9

Table 2.

Grade and Disease Site for Participants with Active cGVHD

cGVHD Site All active cGVHD (n = 59) Grade 1(n = 23) Grade 2 (n = 19) Grade 3 (n = 15)
Eyes 47 23 19 5
Mouth 31 25 6 0
Skin 28 7 11 10
Lungs 27 16 10 1
Joints 24 14 9 1
GI tract 18 15 2 1